期刊文献+

RNAi介导大鼠腺苷A1和A2A受体基因沉默对乙醛诱导的肝星状细胞活化增殖的影响 被引量:4

Proliferation and activation of acetaldehyde-induced HSC-T6 cells through RNA inference targeting adenosine A1 and A2A receptors
下载PDF
导出
摘要 目的研究大鼠腺苷A1受体(A1R)和腺苷A2A(A2AR)受体的siRNA分别转染大鼠肝星状细胞(HSC)对乙醛诱导的HSC活化增殖的影响。方法采用乙醛诱导HSC-T6建立离体的大鼠酒精性肝纤维化HSC模型,设计并合成A1R和A2AR小干扰RNA(small interfering RNA,siRNA)序列,通过脂质体LipofectamineTM2000瞬时转染至HSC-T6细胞内,荧光倒置显微镜观察细胞的转染效率,用四甲基偶氮唑盐(MTT)法检测HSC-T6细胞增殖变化;利用Real-Time q PCR及Western blot法分别检测HSC-T6的A1R、A2AR、α-SMA、Collagen I mRNA及蛋白表达。结果将A1R和A2AR siRNA转染至HSC-T6细胞内,A1R和A2AR基因及蛋白的表达水平明显降低;同时α-SMA、Collagen I mRNA及蛋白表达水平亦明显降低;靶向封闭A1R或A2AR基因的表达可明显抑制HSC-T6细胞的活化增殖。结论靶向封闭A1R或A2AR基因的表达可明显抑制HSC-T6细胞的活化增殖,A1R和A2AR可能是潜在的酒精性肝纤维化的治疗靶点。 Aim To investigate the influence of down-regulating adenosine A1 receptor and adenosine A2 A receptor gene expression on proliferation and activation of acetaldehyde-induced hepatic stellate cell-T6 cells through siRNA. Methods Alcoholic liver fibrosis in vitro model was constructed by inducing HSC-T6 cells with acetaldehyde. siRNA targeting A1R and A2AR were designed and synthesized according to its mRNA. The siRNA was transfected into rat HSC-T6 cells by li-posome LipofectamineTM 2000. HSC cell proliferation was measured by MTT. The mRNA levels of A1R, A2AR, α-SMA, Collagen I in the supernatant of the cell culture were measured by Quantitative Real-Time PCR. The protein levels of A1R, A2AR, α-SMA,Collagen I were measured by Western blot. Results A1 R and A2 AR siRNA effectively inhibited the cell proliferation, and they also significantly decreased the levels of A1R, A2AR,α-SMA, Collagen I, suggesting that A1 R and A2 AR might be potential target genes in the alcoholic liver fibrosis. Conclusions Silencing A1 R or A2 AR by RNAi can significantly inhibit the HSC proliferation, A1R and A2AR may be potential therapeutic target genes for alcoholic liver fibrosis.
出处 《中国药理学通报》 CAS CSCD 北大核心 2015年第1期50-55,共6页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81270498) 安徽省自然科学基金项目(No 11040606M194) 安徽高校省级科学研究重点项目(No KJ2012A148) 国家级大学生创新创业训练计划项目(No 201310366032)
关键词 腺苷A1受体 腺苷A2 A受体 肝星状细胞 细胞增殖 乙醛 酒精性肝纤维化 adenosine A1 receptor adenosine A2 A receptor hepatic stellate cell cell proliferation acetal-dehyde alcoholic liver fibrosis
  • 相关文献

参考文献4

二级参考文献54

  • 1Schwartz J M, Reinus J F. Prevalenceand naturalhistory of alcoholicliver disease [J].Clin Liver Dis, 2012, 16(4): 659-66.
  • 2Fan J G. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[J].Gastroenterol Hepatol, 2013, 28(Suppl 1): 11-7.
  • 3Altamirano J, Bataller R. Alcoholic liver disease: pathogenesis and new targets for therapy[J].Nat Rev Gastroenterol Hepatol, 2011, 8(9): 491-501.
  • 4Leung T M, Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease[J].Hepatology, 2013, 58(2): 395-8.
  • 5Chacko B, Ballinger S W. Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics[J].Biochem Soc Trans, 2013, 41(1): 127-33.
  • 6Ajakaiye M, Jacob A, Wu R, et al. Alcohol and hepatocyte-Kupffer cell interaction (review)[J].Mol Med Report, 2011, 4(4): 597-602.
  • 7Levene A P, Goldin R D. The epidemiology, pathogenesis and histopathology of fatty liver disease[J].Histopathol, 2012, 61(2): 141-52.
  • 8Eid N, Ito Y, Maemura K, Otsuki Y. Elevated autophagic sequestration of mitochondria and lipid droplets in steatotic hepatocytes of chronic ethanol-treated rats: an immunohistochemical and electron microscopic study[J].J Mol Histol, 2013, 44(3): 311-26.
  • 9Bataille A M, Manautou J E. A potential target for new therapeutics in liver disease[J].Clin Pharmacol Ther, 2012, 92(3): 340-8.
  • 10Nishiyama Y, Goda N, Kanai M. HIF-1alpha induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice[J].Hepatology, 2012, 56(2): 441-7.

共引文献84

同被引文献42

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部